FDA Approves Sun Pharma’s ILUMYA for Psoriatic Arthritis

The FDA approved Sun Pharmaceutical Industries’ supplemental application for ILUMYA to treat adults with active psoriatic arthritis, expanding its existing U.S. indication for plaque psoriasis.